price

NASDAQ · OCUL
Ocular Therapeutix, Inc.
Healthcare · Biotechnology
$10.82
Up+$0.05 (+0.46%)
Updated Aug 28, 2026, 5:27 AM
SID Score
5.9/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 2.55B
- P/E ratio
- -10.81
- Dividend yield
- 0.00%
- 52-week range
- $7.38 – $11.74
- Volume
- 1.43M
- Avg. volume
- 3.15M
Price performance
OCUL price history
1M range · 21 trading sessions · Daily adjusted prices
OCUL closed at $10.82 after 21 trading sessions, up 27.74% for the selected period.
- Last close
- $10.82
- Period change
- +27.74%
- Period low
- $8.17
- Period high
- $11.73
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 27, 2026 | $10.63 | $10.955 | $10.57 | $10.82 | 1.43M |
| Aug 26, 2026 | $10.79 | $10.905 | $10.685 | $10.77 | 1.37M |
| Aug 25, 2026 | $10.98 | $11.17 | $10.87 | $10.88 | 1.84M |
| Aug 24, 2026 | $11.03 | $11.05 | $10.61 | $10.78 | 2.36M |
| Aug 21, 2026 | $11.10 | $11.49 | $10.935 | $11.08 | 3.05M |
| Aug 20, 2026 | $11.525 | $11.619 | $11.07 | $11.09 | 3.29M |
| Aug 19, 2026 | $11.29 | $11.74 | $11.185 | $11.73 | 3.02M |
| Aug 18, 2026 | $10.50 | $11.215 | $10.3015 | $11.01 | 4.58M |
| Aug 17, 2026 | $10.80 | $11.195 | $10.50 | $10.65 | 11.15M |
| Aug 14, 2026 | $10.04 | $10.07 | $9.68 | $10.04 | 1.63M |
| Aug 13, 2026 | $10.27 | $10.43 | $10.075 | $10.10 | 2.58M |
| Aug 12, 2026 | $9.77 | $10.43 | $9.74 | $10.23 | 4.01M |
| Aug 11, 2026 | $9.29 | $9.77 | $9.16 | $9.76 | 2.18M |
| Aug 10, 2026 | $9.20 | $9.305 | $9.04 | $9.24 | 1.53M |
| Aug 7, 2026 | $8.80 | $9.20 | $8.80 | $9.19 | 2.02M |
| Aug 6, 2026 | $8.45 | $8.79 | $8.40 | $8.74 | 1.59M |
| Aug 5, 2026 | $8.68 | $8.79 | $8.45 | $8.50 | 1.6M |
| Aug 4, 2026 | $8.40 | $8.715 | $8.355 | $8.59 | 2.23M |
| Aug 3, 2026 | $8.285 | $8.495 | $8.175 | $8.40 | 3.33M |
| Jul 31, 2026 | $8.44 | $8.564 | $8.15 | $8.17 | 2.15M |
| Jul 30, 2026 | $8.37 | $8.53 | $8.27 | $8.47 | 2.69M |
Latest OCUL news
The latest Smart Investors Daily articles mentioning OCUL.
Stock researchCompany · Overview
Loading stock research…

